Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are pleased to present the latest issue of touchREVIEWS in Endocrinology, which offers a timely and thoughtprovoking collection of articles that reflect both the continuity and evolution of diabetes and metabolic disease research. In an era where technology, public health priorities and clinical paradigms are shifting rapidly, this issue highlights the importance of evidence-based […]

US ENDOCRINE DISEASE – VOLUME 2 ISSUE 2 – WINTER 2006

Select a Section…
1

Current Issues

It is now well established that improving glycemic control reduces the risk of microvascular complications, but optimal glycemic control has been elusive.

Three general transplantation approaches are most common, namely, simultaneous pancreas and kidney (SPK); pancreas after kidney (PAK); and pancreas transplant alone (PTA). The one-year, post-transplant pancreas survival rates for these procedures are 79%, 69%, and 69%, respectively, while the five-year organ survival rates are 70%, 45%, and 45%, respectively.The one- and five-year patient survival rates […]

2

Diabetes Management & Glycemic Control

Risk factors have been identified for iatrogenic hypoglycemia, and physiologic studies have revealed the mechanisms of many of these risk factors. Predictors of severe (requiring assistance) hypoglycemia identified through the DCCT include prior history of severe hypoglycemia, longer duration of diabetes, higher baseline glycosylated hemoglobin (HbA1c), and lower treatment HbA1c in type 1 diabetes. The […]

In brief, 1,441 type-1 diabetic individuals were recruited into two cohorts: 726 in a primary prevention cohort with no retinopathy and an albumin excretion rate (AER) of <40mg per 24 hours; and 715 in a secondary intervention cohort with mild to moderate retinopathy and AER 40–200mg per 24 hours. Both genders were equally represented and […]

It is more difficult to implement this goal in the pediatric population, especially due to the increased risk for hypoglycemia in preschool children, as well as fluctuations in insulin requirements caused by exercise, variable carbohydrate intake, and physiological changes due to puberty and age. The possible reduction of hypoglycemia is especially important in children as […]

3

Inhaled Insulin

In order for a particle to be inhaled into the deep lung for transport across the alveolar membrane, it must be of a certain size—between one and three micrometres (μm). Smaller than 1μm, the particle is so light in weight that it will be deposited in the upper airway or exit during exhalation; larger than […]

Although there are many oral hypoglycemic agents to stimulate insulin secretion, reduce insulin resistance, and slow glucose absorption, even combinations of multiple agents often fail to achieve normal HbA1c.2 Perhaps, more important, multiple oral agents (OAs) do not sufficiently reduce postprandial hyperglycemia.3,4 The most effective means of lowering blood sugar is externally administered insulin, particularly […]

Fear of needles and the burden associated with multiple daily injections remain among the most significant barriers to initiating and maintaining insulin therapy. Inhaled human insulin (Exubera® (insulin human (rDNA origin)) Inhalation Powder) is a novel, rapid-acting, insulin formulation administered by inhalation before meals. An extensive clinical trial program including studies for up to two […]

4

Islet Cell Function in Type 2 Diabetes

Immediately these data raise questions: • How much loss of islet cell function can be tolerated without elevation of blood glucose levels? • What was happening in the islets during and beyond the phase leading up to diabetes? • Are these processes modifiable?

In the development of type 2 diabetes, environmental influences (most importantly diet and sedentary lifestyle) and genetic factors lead to the development of insulin resistance (i.e.

In the post-absorptive period (overnight fast), a quasisteady state exists in which the rate of glucose release into plasma approximates its removal. Under these conditions, most of glucose removal from plasma is independent of insulin (i.e. it is largely determined by obligatory tissue demands). For example, glucose uptake by the brain, the formed elements of […]

In addition, GLP-1 has a spectrum of effects thought to be desirable in an antidiabetic agent, including trophic effects on β-cells, inhibition of glucagon secretion, and suppression of food intake and appetite.2,3 The native peptides cannot be used therapeutically because they are rapidly degraded and inactivated by the enzyme, dipeptidyl peptidase-4 (DPP-4). Two strategies have […]

Whether vildagliptin or other agents of this class can modify underlying disease course by improving or preserving α- and β-cell function remains to be determined.

One of the challenges of using anti-diabetic therapy in obese or overweight patients is the prospect of substantial iatrogenic weight gain with many widely used drug classes. Since lifestyle interventions including weight loss are usually very difficult to achieve and/or sustain, the practitioner frequently is left with few options when trying to avoid adverse effects […]

The former was based on a hypothesis that most clinicians would regard as optimistic. The latter was a composite of wishful thinking. PROactive

5

Diabetes & Cardiovascular Risk

The significance of hypertriglyceridemia as a cardiovascular risk factor is further highlighted by its inclusion as a component of the metabolic syndrome, a cluster of metabolic abnormalities, related to insulin resistance. The other criteria for metabolic syndrome include low HDL cholesterol, central obesity, elevated blood pressure, and abnormal fasting glucose. People with metabolic syndrome are […]

Racial and ethnic minorities in the US are disproportionately afflicted with diabetes (see Figure 1 and Table 1) and type-2 diabetes is considerably more common in African-Americans than in whites.3–5 In the Atherosclerosis Risk in Communities Study, the incidence of diabetes was 2.4 times greater in African- American women and 1.5 times greater in African- […]

6

Diabetic Neuropathy & The Diabetic Foot

Pathogenesis of Foot Ulceration

7

Pituitary Disorders

Invasion, proliferation, and metastatic ability are three ways in which tumors take root, grow, and advance. Although proliferative tumors can be invasive, and invasion is a prerequisite to metastasis, none of these qualities automatically links to the others in a given tumor.Thus, each should be considered as sufficient, but not necessary, for a tumor to […]

8

Thyroid Disorders

Much has happened since then. Kendall discovered thyroxine in 1914. Dietary iodine supplementation followed Marine and Kimball’s work on the role of iodine in the treatment of goiter in 1920. Harrington worked out the structure of thyroxine (T4) and synthesized it in 1926. A second and more potent thyroid hormone, triiodothyronine (T3), was discovered and […]

9

Post-menopausal Osteoperosis

Calcitonin is a polypeptide hormone produced by the thyroid gland, and regulates plasma calcium concentration. Calcitonin inhibits the activity of osteoclasts by binding to osteoclast receptors. The net result is an increase in bone mass density (BMD). Calcitonin is US Food and Drug Administration (FDA)-approved for the treatment of postmenopausal osteoporosis in women greater than […]

It has been approved for administration by subcutaneous, intramuscular, and intranasal routes.1,3-8 Because nasal spray calcitonin has been available in the US since 1995 it is extremely rare to use the subcutaneous route for therapy, as it is so much less convenient. Only if there were severe nasal congestion or an underlying condition making spray […]

All postmenopausal women should be advised to avoid smoking and excessive alcohol intake, exercise regularly, and take calcium (1,200–1,500mg daily from food and supplements) and vitamin D (800–1,200 international units (IU) daily). The guidelines for pharmacologic treatment of postmenopausal osteoporosis are not uniform among medical organizations. The pharmacologic options fall into two main categories: antiresorptive […]

10

Puberty Disorders

The onset of puberty is caused by the secretion of highamplitude pulses of gonadotropin-releasing hormone (GnRH) by the hypothalamus. Pulsatile release of GnRH will increase pituitary secretion of lutenizing hormone (LH) and follicle-stimulating hormone (FSH). The hypothesized mechanisms that suppress onset of puberty until the appropriate age include: the hypothalamic-pituitary-gonadal (HPG) axis, which is highly […]

The PROS study led to pediatric endocrinologists, i.e. Lawson Wilkins Pediatric Endocrine Society, proposing new definitions of precocious puberty, viz precocious onset (of puberty) occurs when it is noted at less than six years of age in African-American females and less than seven years in white American otherwise healthy girls. Initiation of Puberty and Pubertal […]

11

Female Sexual Dysfunction

Healthcare, including sexual healthcare, is a fundamental human right.1 Multiple population-based studies reveal a high prevalence of sexual-health concerns in women of all ages.2 A woman’s sexual problems can cause significant personal distress, including a diminution of selfworth and self-esteem, a reduction in life satisfaction and a decline in the quality of her relationship with […]

12

Erectile Dysfunction

13
View All Issues

US Endocrinology is a peer-reviewed, free-to-access, bi-annual journal comprising review articles, case reports, editorials, special reports and original research. It features balanced and comprehensive articles written by leading authorities, addressing the most important and salient developments in the field of endocrinology.

Close Popup